Cargando…
Future insights of pharmacological prevention for AKI post cardiopulmonary bypass surgery (based on PK/PD approach)
The incidence of acute kidney injury (AKI) post-cardiopulmonary bypass (CPB) can cause an increase in the rate of renal replacement therapy (RRT) and mortality rate. Compared to brain and liver damage post-CPB, AKI has the highest incidence of 83%. Based on this phenomenon, various efforts have been...
Autor principal: | Permeisari, Dias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536004/ https://www.ncbi.nlm.nih.gov/pubmed/36210841 http://dx.doi.org/10.3389/fphar.2022.975641 |
Ejemplares similares
-
Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis
por: Krawczeski, Catherine D.
Publicado: (2019) -
Mild AKI is associated with mortality of patients who underwent cardiopulmonary bypass surgery
por: Yang, Yanli, et al.
Publicado: (2020) -
PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017) -
Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
por: Zeitlinger, Markus, et al.
Publicado: (2023) -
PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs
por: Lei, Zhixin, et al.
Publicado: (2018)